Evidence map›Paper›PMID 10973455›Full record

ArticleClinical and diagnostic laboratory immunology2000

Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens.

S Li, G Galvan, F G Araujo, Y Suzuki, J S Remington, S Parmley

Open access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Descriptive Comparison of ELISAs for the Detection ofPathogens (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans.Frontiers in cellular and infection microbiology · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S LiDepartment of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA.
G Galvan
F G Araujo
Y Suzuki
J S Remington
S Parmley
Palo Alto Institute · US

Funding

TOXOPLASMOSIS: NATURE OF INFECTION AND IMMUNE RESPONSER01AI004717 · NIAID · PALO ALTO MEDICAL FOUNDATION RES INST · PI REMINGTON, JACK S · 1985 to 2001
$1.1M
TOXOPLASMOSIS: NATURE OF INFECTION AND IMMUNE RESPONSER37AI004717 · NIAID · PALO ALTO MEDICAL FOUNDATION RES INST · PI REMINGTON, JACK S · 1987 to 1996
–
NIAID NIH HHS AI04717
6 · The paper itself

Abstract

An enzyme-linked immunosorbent assay (ELISA) using four recombinant antigens of Toxoplasma gondii (rP22, rP25, rP29, and rP35) was used in an attempt to differentiate pregnant women with toxoplasma serologic profiles (TSPs) indicative of recently acquired infections (acute profile) from those with TSPs indicative of infections acquired in the distant past (chronic profile). In general, immunoglobulin G antibodies in sera from women with the acute profile reacted more strongly with the recombinant antigens than did those in sera from women with the chronic profile. However, reactivities differed significantly between antigens that reacted with a single serum and between sera that reacted with a single antigen. Because of these variations, we employed a combination of the four antigens in an ELISA (Comb-ELISA) and evaluated its ability to distinguish pregnant women with the acute profile from those with the chronic profile. Eighteen of 20 (90%) sera from acute-profile women were positive in the Comb-ELISA, whereas 69 of 70 (98.6%) sera from the chronic-profile women were negative. Thus, the Comb-ELISA may be useful for diagnosis of toxoplasmosis in pregnant women and for differentiation between recently acquired infections and infections acquired in the more distant past.

Indexed as

Protozoan ProteinsAnimalsAntibodies, ProtozoanAntigens, ProtozoanAntigens, SurfaceEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoblottingImmunoglobulin GPregnancyPregnancy Complications, ParasiticRecombinant Fusion ProteinsSerologic TestsTime FactorsToxoplasmaAntibodies, ProtozoanAntigens, ProtozoanAntigens, SurfaceImmunoglobulin GProtozoan ProteinsRecombinant Fusion Proteinssurface antigen P22, Toxoplasma

Identifiers

PMID10973455
PMCPMC95956
OpenAlexW2130251581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.